(NYSE: SNN) Smith & Nephew's forecast annual revenue growth rate of 5.98% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.12%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.86%.
Smith & Nephew's revenue in 2025 is $5,810,000,134.On average, 22 Wall Street analysts forecast SNN's revenue for 2025 to be $5,496,183,612,732, with the lowest SNN revenue forecast at $5,248,671,032,280, and the highest SNN revenue forecast at $5,693,667,054,582. On average, 22 Wall Street analysts forecast SNN's revenue for 2026 to be $5,777,926,656,438, with the lowest SNN revenue forecast at $5,495,305,908,546, and the highest SNN revenue forecast at $6,030,705,462,006.
In 2027, SNN is forecast to generate $6,072,835,262,934 in revenue, with the lowest revenue forecast at $5,731,408,334,580 and the highest revenue forecast at $6,380,031,728,034.